Scientists create a universal vascular graft with stem cells to improve surgery for cardiovascular disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-May-2025 11:09 ET (3-May-2025 15:09 GMT/UTC)
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib—an FDA-approved drug in the market—and an experimental drug called FGTI-2734, which could make precision medicine more effective for patients with a highly resistant form of lung cancer. The study, featured on the cover of the Journal of Thoracic Oncology, reveals a potential game-changer for patients battling tumors with the KRAS G12C mutation—a driver in about 14% of non-small cell lung cancers.